Dr. Marshall on the Luminary Awards in GI Cancers

John L. Marshall, MD
Published: Tuesday, Nov 14, 2017



John L. Marshall, MD, chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer, discusses the first annual Luminary Awards in GI Cancers, which is honoring five individuals who have devoted their time, talent and resources to improving the care for patients and families affected by GI cancers.

The five honorees are:
  • Julie Fleshman, JD, MBA Pancreatic Cancer Action Network
  • Daniel G. Haller, MD, FACP, FRCP - Abramson Cancer Center, University of Pennsylvania
  • Henry T. Lynch, MD, MS, FACP, FAACR - Creighton University School of Medicine
  • Frank McCormick, PhD, FRS - University of California, San Francisco Helen Diller Family Comprehensive Cancer Center
  • Andrew L. Warshaw, MD, FACS, FRCSED (HON) - Harvard Medical School, Massachusetts General Hospital
The event will take place at 6 pm on December 1 at The St. Regis Washington DC in Washington, DC. Those who are interested can sign up to attend at https://www.onclive.com/luminary-awards.


John L. Marshall, MD, chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer, discusses the first annual Luminary Awards in GI Cancers, which is honoring five individuals who have devoted their time, talent and resources to improving the care for patients and families affected by GI cancers.

The five honorees are:
  • Julie Fleshman, JD, MBA Pancreatic Cancer Action Network
  • Daniel G. Haller, MD, FACP, FRCP - Abramson Cancer Center, University of Pennsylvania
  • Henry T. Lynch, MD, MS, FACP, FAACR - Creighton University School of Medicine
  • Frank McCormick, PhD, FRS - University of California, San Francisco Helen Diller Family Comprehensive Cancer Center
  • Andrew L. Warshaw, MD, FACS, FRCSED (HON) - Harvard Medical School, Massachusetts General Hospital
The event will take place at 6 pm on December 1 at The St. Regis Washington DC in Washington, DC. Those who are interested can sign up to attend at https://www.onclive.com/luminary-awards.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x